Abbott Labs Stock Offers Favorable Entry Point Hosted by MarketBeat StaffOctober 26, 2023 ShareLink copied to clipboard. Play video for Abbott Labs Stock Offers Favorable Entry PointDetailsGuestsAbbott Laboratories' share price has trended lower for nearly two years, but that trend is over. The impact of the pandemic on sales and the post-pandemic letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization, a buzzword that can be applied to most industries today, means steadying sales of supplies offset by core business growth and, more importantly, a return to growth for this Dividend King in 2024.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABTAbbott Laboratories4.7541 of 5 stars4.75 / 5 stars$113.86+0.7%1.93%35.47 Add This Stock to My Watchlist Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | Sponsored7 Housing Stocks to Buy Regardless of Interest Rate ChangesAccording to the Bankrate survey of large lenders, the average interest rate on a 30-year fixed-rate mortgage ...MarketBeatThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | Sponsored7 of the Best Options for Investing $5,000 in 2025Part of managing your money is taking calculated risks to help your money work for you. That means, whether yo...MarketBeatPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredThe Best Energy Stocks to Buy NowWith recent disruptions in the international energy markets, there has been a renewed attention on public ener...MarketBeat Recent Videos Featured Articles and OffersWhy NVIDIA Is More of a Screaming Buy Than EverSeptember 5, 2024View Why NVIDIA Is More of a Screaming Buy Than EverKamala’s Dirty Election Move… RevealedFrom Paradigm Press(Ad)View Kamala’s Dirty Election Move… Revealed3 Undervalued Stocks That Are Surprisingly Cheap Right NowSeptember 3, 2024View 3 Undervalued Stocks That Are Surprisingly Cheap Right NowThe Fundamental Issue With NVIDIA Might Be Its FundamentalsSeptember 6, 2024View The Fundamental Issue With NVIDIA Might Be Its FundamentalsAutodesk Stock: Analysts' Top AI Pick You Shouldn’t OverlookSeptember 2, 2024View Autodesk Stock: Analysts' Top AI Pick You Shouldn’t OverlookCNBC’s ‘Prophet’ issues urgent Fed warningFrom Stansberry Research(Ad)View CNBC’s ‘Prophet’ issues urgent Fed warning Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by MarketBeat StaffOctober 26, 2023 ShareLink copied to clipboard. Play video for Abbott Labs Stock Offers Favorable Entry PointDetailsGuestsAbbott Laboratories' share price has trended lower for nearly two years, but that trend is over. The impact of the pandemic on sales and the post-pandemic letdown were cause enough for the market to sell, but not now; the market is oversold and overextended with normalization at hand. Normalization, a buzzword that can be applied to most industries today, means steadying sales of supplies offset by core business growth and, more importantly, a return to growth for this Dividend King in 2024.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioABTAbbott Laboratories4.7541 of 5 stars4.75 / 5 stars$113.86+0.7%1.93%35.47 Add This Stock to My Watchlist Thomas Hughes, GuestMarketBeat Contributor, MarketBeatThomas got his start with the markets while working as a Chef. In 2005 a chance invitation to attend the seminar “How To Buy And Sell Your Own Stocks” altered his worldview. Soon trading and stocks consumed his every waking moment to the point of excluding all else. Thomas now enjoys a much different lifestyle engaged in his true passion, uncovering great investments.Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube More From MarketBeatPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | Sponsored7 Housing Stocks to Buy Regardless of Interest Rate ChangesAccording to the Bankrate survey of large lenders, the average interest rate on a 30-year fixed-rate mortgage ...MarketBeatThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | Sponsored7 of the Best Options for Investing $5,000 in 2025Part of managing your money is taking calculated risks to help your money work for you. That means, whether yo...MarketBeatPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredThe Best Energy Stocks to Buy NowWith recent disruptions in the international energy markets, there has been a renewed attention on public ener...MarketBeat